News

Antios Therapeutics Doses First Patients in SAVE 1, a Phase 2a study of ATI-2173

Apr. 21, 2021

Antios Therapeutics Raises $96 Million in a Series B Financing

Apr. 12, 2021

Monte Rosa Therapeutics Strengthens Leadership

Feb. 25, 2021

Arcellx Announces Executive Appointments

Apr. 19, 2021

Schrödinger Teams Build All-in-One Supercomputing Solution with Nvidia

Apr. 12, 2021

Pipeline Therapeutics Completes $80 Million Series C Financing

Feb. 11, 2021

Arcellx Closes $115 Million Series C Financing

Apr. 13, 2021

Monte Rosa Therapeutics Announces $95 Million Series C

Mar. 12, 2021

GrubMarket Raised $90 Million in 2020

Feb. 9, 2021